KATHRYN HARGROVE: Open Payments
NPI 1013751759 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,536 in 217 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $1,629 · 2025 $4,536
Food & beverage: $4,452Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 61 | $1,181 |
| Janssen Biotech, Inc. | 33 | $666 |
| Ardelyx, Inc. | 21 | $474 |
| Madrigal Pharmaceuticals | 14 | $430 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 28 | $402 |
| GENZYME CORPORATION | 10 | $306 |
| Lilly USA, LLC | 10 | $238 |
| Phathom Pharmaceuticals, Inc. | 8 | $195 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $183 |
| Gilead Sciences, Inc. | 4 | $98 |
Products named: TREMFYA, IBSRELA, REZDIFFRA, SKYRIZI, RINVOQ, DUPIXENT, RELISTOR, OMVOH.
Industry payments across AL — which companies pay providers there.
